slotkoers
Korea S.E.
00:00:00 30-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
4.705
KRW
|
-0,32%
|
|
+0,11%
|
-10,89%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
61.527
|
66.725
|
108.199
|
130.082
|
102.750
|
85.445
|
Bedrijfswaarde
1 |
61.225
|
66.821
|
107.646
|
118.985
|
111.249
|
92.497
|
K/w-verhouding
|
18,7
x
|
15,1
x
|
90,7
x
|
-49,7
x
|
-16,4
x
|
-11,9
x
|
Dividendrendement
|
1,9%
|
1,85%
|
1,44%
|
1,34%
|
1,69%
|
-
|
Marktkapitalisatie/omzet
|
0,74
x
|
0,73
x
|
1,1
x
|
1,12
x
|
0,74
x
|
0,62
x
|
Bedrijfswaarde/omzet
|
0,74
x
|
0,74
x
|
1,1
x
|
1,03
x
|
0,8
x
|
0,67
x
|
Bedrijfswaarde/EBITDA
|
8,21
x
|
5,97
x
|
10,6
x
|
20,9
x
|
25,1
x
|
19
x
|
Bedrijfswaarde/FCF
|
-11,1
x
|
13,7
x
|
-5,88
x
|
-88,1
x
|
-9,14
x
|
-12,3
x
|
FCF Yield
|
-8,99%
|
7,3%
|
-17%
|
-1,14%
|
-10,9%
|
-8,14%
|
Price to Book
|
0,73
x
|
0,76
x
|
0,96
x
|
1,07
x
|
0,89
x
|
0,78
x
|
Aantal aandelen (in duizenden)
|
11.719
|
11.758
|
14.822
|
16.656
|
16.519
|
16.183
|
Referentieprijs
2 |
5.250
|
5.675
|
7.300
|
7.810
|
6.220
|
5.280
|
Datum van publicatie
|
20/03/19
|
18/03/20
|
17/03/21
|
23/03/22
|
22/03/23
|
20/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
83.096
|
90.878
|
98.120
|
115.655
|
138.881
|
137.210
|
EBITDA
1 |
7.455
|
11.195
|
10.170
|
5.703
|
4.435
|
4.858
|
Bedrijfsresultaat (EBIT)
1 |
5.328
|
8.075
|
6.271
|
1.200
|
-592,1
|
-748,9
|
Operationele Marge
|
6,41%
|
8,89%
|
6,39%
|
1,04%
|
-0,43%
|
-0,55%
|
Resultaat voor belastingen (EBT)
1 |
4.648
|
6.600
|
3.711
|
-383,2
|
-3.810
|
-5.442
|
Nettowinst (verlies)
1 |
4.020
|
4.722
|
1.284
|
-2.214
|
-5.988
|
-7.181
|
Nettomarge
|
4,84%
|
5,2%
|
1,31%
|
-1,91%
|
-4,31%
|
-5,23%
|
WPA
2 |
281,5
|
376,3
|
80,44
|
-157,0
|
-378,3
|
-443,0
|
Free Cash Flow
1 |
-5.505
|
4.880
|
-18.305
|
-1.351
|
-12.176
|
-7.527
|
FCF-marge
|
-6,63%
|
5,37%
|
-18,66%
|
-1,17%
|
-8,77%
|
-5,49%
|
Kasstroomconversie (ebitda)
|
-
|
43,59%
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
103,34%
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
100,0
|
105,0
|
105,0
|
105,0
|
105,0
|
-
|
Datum van publicatie
|
20/03/19
|
18/03/20
|
17/03/21
|
23/03/22
|
22/03/23
|
20/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
96,3
|
-
|
-
|
8.499
|
7.053
|
Nettokaspositie
1 |
302
|
-
|
553
|
11.097
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
0,008604
x
|
-
|
-
|
1,916
x
|
1,452
x
|
Free Cash Flow
1 |
-5.505
|
4.880
|
-18.305
|
-1.351
|
-12.176
|
-7.527
|
ROE (netto-inkomsten/eigen vermogen)
|
5,08%
|
6,27%
|
2,32%
|
-0,75%
|
-3,51%
|
-4,55%
|
ROA (netto-inkomsten/totale activa)
|
2,59%
|
3,7%
|
2,68%
|
0,43%
|
-0,19%
|
-0,24%
|
Totale activa
1 |
154.978
|
127.702
|
47.916
|
-513.404
|
3.141.489
|
3.018.454
|
Nettoactief per aandeel
2 |
7.210
|
7.433
|
7.579
|
7.306
|
6.986
|
6.773
|
Cashflow per aandeel
2 |
2.301
|
2.283
|
1.362
|
3.018
|
1.580
|
1.892
|
Capex
1 |
9.763
|
8.056
|
12.047
|
6.073
|
5.283
|
4.514
|
Capex/omzet
|
11,75%
|
8,87%
|
12,28%
|
5,25%
|
3,8%
|
3,29%
|
Datum van publicatie
|
20/03/19
|
18/03/20
|
17/03/21
|
23/03/22
|
22/03/23
|
20/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -10,89% | 55,01 mln. | | +3,37% | 69,25 mld. | | +12,55% | 9 mld. | | -12,75% | 4,96 mld. | | +42,38% | 4,47 mld. | | +5,23% | 3,9 mld. | | +18,90% | 2,45 mld. | | -19,05% | 2,41 mld. | | -28,72% | 2,23 mld. | | +11,13% | 2,02 mld. |
Specialiteit & Geavanceerde Farmaceutische Producten
|